1. Home
  2. GNTA vs POAS Comparison

GNTA vs POAS Comparison

Compare GNTA & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.63

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$1.50

Market Cap

22.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GNTA
POAS
Founded
2014
2017
Country
Italy
Singapore
Employees
13
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
22.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GNTA
POAS
Price
$0.63
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.6K
287.3K
Earning Date
03-24-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.53
52 Week High
$10.00
$7.40

Technical Indicators

Market Signals
Indicator
GNTA
POAS
Relative Strength Index (RSI) 25.64 40.88
Support Level N/A $1.41
Resistance Level $1.70 $2.27
Average True Range (ATR) 0.08 0.26
MACD -0.02 0.07
Stochastic Oscillator 8.95 9.88

Price Performance

Historical Comparison
GNTA
POAS

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: